Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
612 | 13263 | 41.1 | 75% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
54 | 89702 | MENOPAUSE//POLYCYSTIC OVARY SYNDROME//ESTROGEN |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
88 | 4356 | POLYCYSTIC OVARY SYNDROME//PCOS//HYPERANDROGENISM |
734 | 3051 | HYPOGONADISM//LATE ONSET HYPOGONADISM//TESTOSTERONE REPLACEMENT THERAPY |
3000 | 2014 | DEHYDROEPIANDROSTERONE//DHEA//DEHYDROEPIANDROSTERONE SULFATE |
6765 | 1370 | CORTICOSTEROID BINDING GLOBULIN//SEX STEROID BINDING PROTEIN//SEX HORMONE BINDING GLOBULIN |
8685 | 1159 | COMPREHENS OBES//CELLULAR MOL SPORTS MED//ARKO MOUSE |
8759 | 1151 | HIRSUTISM//IDIOPATHIC HIRSUTISM//3 ALPHA ANDROSTANEDIOL GLUCURONIDE |
28812 | 162 | SHBG GENE POLYMORPHISM//CLIN MED CHEM MED//ENDOCRINE SECT INTERNAL MED 3 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | POLYCYSTIC OVARY SYNDROME | Author keyword | 1301 | 57% | 11% | 1521 |
2 | PCOS | Author keyword | 398 | 50% | 4% | 579 |
3 | HYPERANDROGENISM | Author keyword | 270 | 56% | 2% | 331 |
4 | HIRSUTISM | Author keyword | 234 | 55% | 2% | 292 |
5 | DEHYDROEPIANDROSTERONE | Author keyword | 222 | 44% | 3% | 387 |
6 | HYPOGONADISM | Author keyword | 182 | 35% | 3% | 429 |
7 | TESTOSTERONE | Author keyword | 145 | 11% | 9% | 1208 |
8 | DHEA | Author keyword | 134 | 41% | 2% | 257 |
9 | LATE ONSET HYPOGONADISM | Author keyword | 133 | 83% | 1% | 76 |
10 | TESTOSTERONE REPLACEMENT THERAPY | Author keyword | 114 | 75% | 1% | 82 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | POLYCYSTIC OVARY SYNDROME | 1301 | 57% | 11% | 1521 | Search POLYCYSTIC+OVARY+SYNDROME | Search POLYCYSTIC+OVARY+SYNDROME |
2 | PCOS | 398 | 50% | 4% | 579 | Search PCOS | Search PCOS |
3 | HYPERANDROGENISM | 270 | 56% | 2% | 331 | Search HYPERANDROGENISM | Search HYPERANDROGENISM |
4 | HIRSUTISM | 234 | 55% | 2% | 292 | Search HIRSUTISM | Search HIRSUTISM |
5 | DEHYDROEPIANDROSTERONE | 222 | 44% | 3% | 387 | Search DEHYDROEPIANDROSTERONE | Search DEHYDROEPIANDROSTERONE |
6 | HYPOGONADISM | 182 | 35% | 3% | 429 | Search HYPOGONADISM | Search HYPOGONADISM |
7 | TESTOSTERONE | 145 | 11% | 9% | 1208 | Search TESTOSTERONE | Search TESTOSTERONE |
8 | DHEA | 134 | 41% | 2% | 257 | Search DHEA | Search DHEA |
9 | LATE ONSET HYPOGONADISM | 133 | 83% | 1% | 76 | Search LATE+ONSET+HYPOGONADISM | Search LATE+ONSET+HYPOGONADISM |
10 | TESTOSTERONE REPLACEMENT THERAPY | 114 | 75% | 1% | 82 | Search TESTOSTERONE+REPLACEMENT+THERAPY | Search TESTOSTERONE+REPLACEMENT+THERAPY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HORMONE BINDING GLOBULIN | 424 | 40% | 6% | 822 |
2 | SYNDROME PCOS | 409 | 71% | 2% | 328 |
3 | HYPOGONADAL MEN | 365 | 49% | 4% | 543 |
4 | HYPERANDROGENISM | 344 | 54% | 3% | 445 |
5 | LATE ONSET HYPOGONADISM | 339 | 74% | 2% | 249 |
6 | HYPERANDROGENIC WOMEN | 293 | 83% | 1% | 167 |
7 | LOW SERUM TESTOSTERONE | 285 | 73% | 2% | 217 |
8 | ANDROGEN EXCESS | 282 | 67% | 2% | 254 |
9 | ANDROGEN DEFICIENCY | 273 | 64% | 2% | 269 |
10 | IDIOPATHIC HIRSUTISM | 259 | 78% | 1% | 173 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AGING MALE | 50 | 37% | 1% | 106 |
2 | GYNECOLOGICAL ENDOCRINOLOGY | 39 | 12% | 2% | 311 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis | 2011 | 198 | 205 | 81% |
Medical progress: Polycystic ovary syndrome | 2005 | 718 | 124 | 87% |
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials | 2013 | 90 | 83 | 72% |
The sexual dimorphism of obesity | 2015 | 8 | 66 | 36% |
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report | 2009 | 364 | 246 | 63% |
Testosterone and metabolic syndrome | 2015 | 3 | 44 | 86% |
Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis | 2011 | 150 | 49 | 84% |
Polycystic ovary syndrome | 2007 | 337 | 157 | 82% |
Sex differences of endogenous sex hormones and risk of type 2 diabetes - A systematic review and meta-analysis | 2006 | 480 | 113 | 77% |
MEDICAL PROGRESS - POLYCYSTIC-OVARY-SYNDROME | 1995 | 1060 | 109 | 80% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ROBERT HAGUE DIABET ENDOCRINOL | 53 | 95% | 0.1% | 18 |
2 | ANDROGEN RELATED DISORDERS | 41 | 90% | 0.1% | 18 |
3 | MENS HLTH BOSTON | 24 | 91% | 0.1% | 10 |
4 | ENDOCRINOL HUMAN REPROD | 22 | 41% | 0.3% | 41 |
5 | SCI AFFAIRS MENS HEALTHCARE | 17 | 75% | 0.1% | 12 |
6 | DIABET OBES HUMAN REPROD GRP | 16 | 64% | 0.1% | 16 |
7 | PL UROL | 16 | 64% | 0.1% | 16 |
8 | INTERACAO NEUROHUMORAL | 15 | 82% | 0.1% | 9 |
9 | GYNECOL ENDOCRINOL UNIT | 15 | 36% | 0.2% | 33 |
10 | ENDOCRINOL METAB MOL MED | 15 | 15% | 0.7% | 89 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000011301 | FERTILITY AND STERILITY//IVF//OVARIAN HYPERSTIMULATION SYNDROME |
2 | 0.0000010411 | ERECTILE DYSFUNCTION//JOURNAL OF SEXUAL MEDICINE//INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH |
3 | 0.0000009745 | METABOLIC SYNDROME//WAIST CIRCUMFERENCE//ABDOMINAL OBESITY |
4 | 0.0000009605 | CONGENITAL ADRENAL HYPERPLASIA//21 HYDROXYLASE DEFICIENCY//CYP21A2 |
5 | 0.0000009134 | MENOPAUSE//HORMONE REPLACEMENT THERAPY//MATURITAS |
6 | 0.0000008562 | MAMMOGRAPHIC DENSITY//BREAST DENSITY//CANCER CAUSES & CONTROL |
7 | 0.0000007918 | DOPING CONTROL//EPITESTOSTERONE//DOPING ANALYSIS |
8 | 0.0000007443 | ALLOPREGNANOLONE//PREMATURE EJACULATION//NEUROSTEROID |
9 | 0.0000006577 | TESTIS//SERTOLI CELLS//SPERMATOGENESIS |
10 | 0.0000006193 | MARE//ANABOLIC ANDROGENIC STEROIDS//TAYLORELLA EQUIGENITALIS |